Skip to main content
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2014 May 14;16(11):3146–3149. doi: 10.1021/ol501297a

Silyl Imine Electrophiles in Enantioselective Catalysis: A Rosetta Stone for Peptide Homologation, Enabling Diverse N-Protected Aryl Glycines from Aldehydes in Three Steps

Dawn M Makley 1, Jeffrey N Johnston 1,*
PMCID: PMC4059254  PMID: 24828455

Abstract

graphic file with name ol-2014-01297a_0010.jpg

We report that N-(trimethylsilyl)imines serve in the Bis(AMidine)-catalyzed addition of bromonitromethane with a high degree of enantioselection. This allows for the production of a range of protected α-bromo nitroalkane donors (including Fmoc) for use in Umpolung Amide Synthesis (UmAS). Hence, peptide homologation with nonnatural aryl glycine amino acids is achieved in three steps from aromatic aldehydes, which are plentiful and inexpensive. Epimerization during the homologation step is circumvented by avoiding an α-amino acid intermediate.


Despite the tremendous achievements of conventional dehydrative amide synthesis,1 opportunities abound for the study of peptides containing nonnatural amino acids. As an increasing number of peptides reach commercial end points,2,3 the demand for new methods that might address amide and peptide preparatory needs has only increased.4,5 Umpolung Amide Synthesis (UmAS), an amide preparation that expresses the ability of α-halo nitroalkanes (D, Figure 1) to function as carboxylic acid surrogates in a direct synthesis of amides,6 may play a key role in solving this problem. Chiral nonracemic donors D were prepared from N-Boc-imine electrophiles (B, R = OtBu),7 but we soon realized that alternative protecting groups at nitrogen would be desirable, if not preferred, for applications in complex peptide synthesis (e.g., aryl glycine-rich natural products).8 This report describes access to aryl glycine donors for UmAS using N-(trimethylsilyl)imines (A) as unlikely electrophiles for the enantioselective aza-Henry addition of bromonitromethane. Furthermore, the silyl amine intermediates (C) may be functionalized by a range of protecting groups, including Fmoc.9 The resulting procedure can be used to homologate an amine with a non-natural amino acid in the shortest sequence yet from inexpensive starting materials.

Figure 1.

Figure 1

Parallel strategies to prepare aryl glycine α-bromo nitroalkane donors for Umpolung amide synthesis.

The early impact of N-silylimine substrates was driven heavily by nucleophilic addition reactions of strong nucleophiles.10 Itsuno reported the use of N-silylimines in enantioselective synthesis with organoborane additions, providing the products of carbon nucleophilic addition in up to 96% ee.11,12 These transformations utilize a stoichiometric amount of the chiral amino alcohol but provide convenient access to a range of homoallylic amines since the nitrogen–silicon bond is cleaved hydrolytically during workup.12 More recent work has established that silyl imines are competent electrophiles for fluoronium catalysis13 and α-amino boronic acid synthesis.14 Insofar as N-TMS imines are considerably more Lewis basic and less electrophilic than N-acylimines,15 a catalyst complement would need to simultaneously activate the imine and mitigate both imine polymerization and further addition of the desired adduct to imine. Indeed, our early attempts were plagued by the formation of products such as E.

Our studies began with the preparation of p-chloro N-TMS benzaldimine 9 (A, Figure 1) using the Collet protocol16 and its conversion to the corresponding N-Fmoc derivative (AB, Figure 1) by treatment with Fmoc-Cl. This acylation suffered from poor conversion, and the N-Fmoc derivative was not isolated in pure form. However, when the crude product was subjected to bromonitromethane and catalyst PBAM (1)17,18 at −20 °C, the addition product was obtained in 28% yield (two steps, as a mixture of diastereomers) with 84/83% ee (for the major/minor diastereomer, respectively). While the ee of this reaction was pleasing, the low yield led us to explore other options—specifically, a direct aza-Henry addition to the N-TMS-imine. Our experience with aza-Henry adducts from N-alkylimines has shown that they undergo reversible addition upon standing, leading to racemization. That behavior, combined with the large silyl group at the putative substrate binding site and less polarized azomethine, suggested a low possibility for success. Notwithstanding, the N-TMS-imine was subjected to bromonitromethane directly with electron-rich bis(amidine) catalyst 1 at ambient temperature. Though the resulting adduct could not be isolated, it could be observed directly by NMR (1H/13C).19 Immediate treatment of the crude adduct with Fmoc-Cl delivered the α-bromo nitroalkane (10e) in 43% yield and 11% ee (for each diastereomer) from 9.

Even the low level of stereoselection observed in this reaction was surprising, and it prompted an expanded investigation of catalysts that might promote the addition (Table 1). The reaction temperature was lowered to −78 °C, and acetyl bromide was used to quench the resulting TMS-adduct. This provided an increase in stereoselection to the 80% ee level (Table 1, entry 1). Use of a single equivalent, as well as a slight excess of triflic acid relative to the ligand, led to progressively lower reactivities and enantioselectivities (Table 1, entries 2 and 3).20 Less electron-rich bis(amidine) catalysts provided lower enantioselection (Table 1, entries 4 and 5),21 and a catalyst that had provided excellent enantioselection with N-Boc-imine substrates also fared poorly with the corresponding silyl imine (Table 1, entry 6).6 Finally, an examination of two catalysts common to the thiourea catalysis field provided disappointing preliminary results (Table 1, entries 7 and 8).22

Table 1. Enantioselective Additions of Bromonitromethane to N-TMS Imines: Catalyst Investigation.

graphic file with name ol-2014-01297a_0003.jpg

entrya catalyst eeb (%) yieldc (%)
1 PBAM (1) 80, 81 56
2 PBAM·HOTf 1:1 (2) 60, 61 19
3 PBAM·HOTf 2:3 (3) 38, 40 10
4 H-Quin-BAM (4) 33, 32 18
5 4-MeO-BAM (5) 24, 23 17
6 Anth-PBAM (6) 35, 32 47
7 thiourea 7 –16, −17 42
8 thiourea 8 8, 3 34
9d PBAM (1) 32, 30 40
10d PBAM (1) 89, 88 8
11d PBAM (1) 93, 91 78
a

Reactions stirred at −78 °C for 8 h. Then acetyl bromide was added, and the reactions were stirred additional 2 h before being quenched with water at −78 °C.

b

Adducts isolated as a mixture of diastereomers (dr = 1:1 up to 3:1, see the Supporting Information), ee’s reported for (major, minor) diastereomer.

c

Low yields generally correspond to poor reactivity of the catalyst, resulting in low conversions.

d

Bromonitromethane used: entry 9, 300 mol %; entry 10, 30 mol %; entry 11, 20 mol % added every 2 h, 100 mol % total, and 10 mol % catalyst.d

A significant sensitivity of enantioselection to bromonitromethane concentration was also uncovered. If an excess of bromonitromethane was used, the apparent reactivity was lowered along with the measured ee for the adducts (Table 1, entry 9). Conversely, limiting the pronucleophile concentration provided an enhancement of ee from 81 to 89% (Table 1, cf. entries 1 and 10). Addition of bromonitromethane in 20 mol % increments evenly over 10 h led to excellent enantioselection at the 93/91% ee level (Table 1, entry 11) with a 10 mol % catalyst loading to ensure low bromonitromethane concentrations throughout the reaction.

Our primary goal of this study was to address the need to extend UmAS to carboxylic acid surrogates containing N-protecting groups other than Boc. Therefore, immediately after formation of the aza-Henry adduct, the acylation reagent was added to the reaction mixture at low temperature. We found it prudent to replace the cryogenic bath with an ice–water bath at this point, since the acylation was relatively slow in some cases. This practice ensured complete conversion of the intermediate silyl amine. Both acetyl bromide and acetyl chloride provided similar outcomes (Table 2, entries 1 and 2). Aromatic and hindered acid chlorides provided highly enantioenriched products in comparable yield (Table 2, entries 3 and 4). α-Azido acetyl chloride also performed well, delivering the product in 82% yield and 91% ee for both diastereomers (Table 2, entry 5). The heavy reliance on Fmoc-protected amino acids in solid-phase peptide synthesis made it a priority problem to solve (Table 2, entry 6). The versatile Cbz- and Alloc-protected amino acids are also now available through the synthesis of both 10f and 10g in good yield and with good enantioselection (Table 2, entries 7 and 8).

Table 2. Enantioselective α-Bromo Nitroalkane Synthesis: Functionalization of the Silyl Amine Adducta.

graphic file with name ol-2014-01297a_0005.jpg

entry RX   eeb (%) yield (%) entry RX   eeb (%) yield (%)
1 AcBr a 93, 91 78 5 N3AcCl d 91, 91 82
2 AcCl a 92, 91 83 6 FmocCl e 91, 91 76
3 BzCl b 94, 95 70 7 CbzCl f 91, 90 72
4 PivCl c 96, 97 67 8 AllocCl g 91, 91 85
a

100 mol % bromonitromethane added in aliquots over 10 h (0.2 equiv/2 h) before stirring overnight. The acylating agent (1 equiv) was then added and an ice–water bath applied.

b

Adducts isolated in dr = 1:1 up to 3:1 (see the Supporting Information); ee’s reported for (major, minor).

The initial scope of this approach to aryl glycine donors for use in UmAS was elucidated in the context of Fmoc-protected donor synthesis (Table 3). Halogenated aryl glycines bearing a variety of substitution patterns provided good enantioselection and good overall isolated yields of the Fmoc-protected α-bromo nitroalkanes 12a-e (Table 3, entries 1–5). Electron-deficient and neutral silyl aldimines (Table 3, entries 6 and 7, respectively) provided slightly depressed enantioselection that would correspond to approximately 9:1 dr after UmAS coupling with a chiral amine. This behavior is improved slightly with the tolyl and 2-naphthyl cases (Table 3, entries 8 and 9), and our initial investigation of the p-methoxy case (Table 3, entry 10) places it within this category as well. In all cases, it is significant to note that the diastereomeric addition products are homochiral (R) at the benzylic carbon.23

Table 3. Enantioselective Synthesis of Fmoc-Protected α-Bromonitroalkanesa.

graphic file with name ol-2014-01297a_0006.jpg

graphic file with name ol-2014-01297a_0007.jpg

a

100 mol % bromonitromethane added in aliquots over 10 h (0.2 equiv/2 h) before stirring overnight. The acylating agent (1 equiv) was then added and an ice–water bath applied. See the Supporting Information for complete experimental details and analytical data.

b

Adducts isolated as a mixture of diastereomers (dr = 1:1 up to 3:1, see the Supporting Information), ee’s reported for (major, minor) diastereomer.

The enantioselectivity with which adducts 10ag are formed (Table 2) correlates directly to the diastereomeric ratio of the amide products resulting from their coupling to enantiopure amino acids using UmAS (Table 4). For example, α-bromonitroalkanes 10dg, listed in Table 2, were coupled to a variety of chiral nonracemic α-amino esters and amines to establish the overall efficiency of this approach to aryl glycinamide synthesis (Table 4). In all cases, the enantiomeric ratio of the donors translated into high diastereomeric ratios for the amide products, indicating the absence of epimerization. Of particular note is the tolerance of the Fmoc-protected donor to the basic reaction conditions.

Table 4. Coupling of Protected α-Bromo Nitroalkane Donors to Amines Using UmASa.

graphic file with name ol-2014-01297a_0008.jpg

graphic file with name ol-2014-01297a_0009.jpg

a

Reaction run in THF, with 1.2 equiv of amine for 24 h at 0 °C.

b

Reaction run with 2 equiv of amine, for 24 h at 0 °C, under an atmosphere of O2.

c

Reaction run with 1.2 equiv of amine, for 4 h at 0 °C, under an atmosphere of O2.

d

Measured by 1H HMR.

In summary, we have discovered that N-TMS imines are effective electrophiles in the BAM-catalyzed enantioselective addition of bromo nitromethane and that the intermediate N-TMS adduct can be acylated in situ. This provides a range of adducts that can be used in Umpolung amide synthesis, delivering the amino acid derivative, homologated by an aryl glycine, with high diastereomeric purity. In some cases, such as Fmoc-protected 10e, the product can be prepared by either pathway via B or C (Figure 1) with similarly high enantioselection.24 However, the low yield observed in the former case further emphasizes the practical value of the pathway through C. In other comparisons, such as the acyl-protected 10a, the increased reactivity of the acyl imine intermediate leads to poor enantioselection and yield. The development of N-TMS imines as substrates in the enantioselective synthesis of amides and peptides both decreases the length from aryl aldehyde to peptide to three steps and broadens the nitrogen substituent choices, including Fmoc protection without extensive redevelopment of the enantioselective reaction for each case. In this way, silyl amines C are Rosetta Stones for α-amino amide synthesis.

Acknowledgments

Unrestricted support from Amgen and the ACS Division of Organic Chemistry (graduate fellowship to D.M.M.) is gratefully acknowledged, as is partial support by the NIH (GM 063557 (exploratory) and GM 084333 (catalyst development)).

Supporting Information Available

Complete preparatory and analytical data for all new compounds. This material is available free of charge via the Internet at http://pubs.acs.org.

The authors declare no competing financial interest.

Funding Statement

National Institutes of Health, United States

Supplementary Material

ol501297a_si_001.pdf (501.2KB, pdf)
ol501297a_si_002.pdf (855.2KB, pdf)

References

  1. Review:Valeur E.; Bradley M. Chem. Soc. Rev. 2009, 38, 606. [DOI] [PubMed] [Google Scholar]
  2. Erickson G. W. J. Pept. Sci. 2004, 10, 101. [Google Scholar]; Liu S. W.; Lu H.; Niu J.; Xu Y. J.; Wu S. G.; Jiang S. B. J. Biol. Chem. 2005, 280, 11259. [DOI] [PubMed] [Google Scholar]; Thayer A. M. Chem. Eng. News 2011, 89, 21. [Google Scholar]
  3. Peptides as Drugs: Discovery and Development; Groner B., Ed.; Wiley-VHC: Weinheim, 2009. [Google Scholar]; Bray B. L. Nat. Rev. Drug Discov. 2003, 2, 587. [DOI] [PubMed] [Google Scholar]
  4. For a review of emerging methods in amide and peptide synthesis, see:Bode J. W. Curr. Opin. Drug Discovery Dev. 2006, 9, 765. [PubMed] [Google Scholar]; Recent examples:; Cassidy M. P.; Raushel J.; Fokin V. V. Angew. Chem., Int. Ed. 2006, 45, 3154. [DOI] [PubMed] [Google Scholar]; Yoo W.-J.; Li C.-J. J. Am. Chem. Soc. 2006, 128, 13064. [DOI] [PubMed] [Google Scholar]; Chan W.-K.; Ho C.-M.; Wong M.-K.; Che C.-M. J. Am. Chem. Soc. 2006, 128, 14796. [DOI] [PubMed] [Google Scholar]; Gunanathan C.; Ben-David Y.; Milstein D. Science 2007, 317, 790. [DOI] [PubMed] [Google Scholar]; Nordstrom L. U.; Vogt H.; Madsen R. J. Am. Chem. Soc. 2008, 130, 17672. [DOI] [PubMed] [Google Scholar]; Gao J.; Wang G.-W. J. Org. Chem. 2008, 73, 2955. [DOI] [PubMed] [Google Scholar]; Li X.; Danishefsky S. J. J. Am. Chem. Soc. 2008, 130, 5446. [DOI] [PMC free article] [PubMed] [Google Scholar]; Rao Y.; Li X.; Danishefsky S. J. J. Am. Chem. Soc. 2009, 131, 12924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Recent developments in the enantioselective synthesis of non-natural amino acids: Sharpless aminohydroxylation:Reddy K. L.; Sharpless K. B. J. Am. Chem. Soc. 1998, 120, 1207. [Google Scholar]; Asymmetric hydrogenation:; Shang G.; Yang Q.; Zhang X. M. Angew. Chem., Int. Ed. 2006, 45, 6360. [DOI] [PubMed] [Google Scholar]; Asymmetric addition of arylboronic acids to imino esters:; Beenen M. A.; Weix D. J.; Ellman J. A. J. Am. Chem. Soc. 2006, 128, 6304. [DOI] [PubMed] [Google Scholar]; Dai H. X.; Yang M.; Lu X. Y. Adv. Synth. Catal. 2008, 350, 249. [Google Scholar]; Asymmetric N–H insertion:; Lee E. C.; Fu G. C. J. Am. Chem. Soc. 2007, 129, 12066. [DOI] [PubMed] [Google Scholar]; Xu B.; Zhu S.-F.; Xie X.-L.; Shen J.-J.; Zhou Q.-L. Angew. Chem., Int. Ed. 2011, 50, 11483. [DOI] [PubMed] [Google Scholar]; Asymmetric Strecker:; Zuend S. J.; Coughlin M. P.; Lalonde M. P.; Jacobsen E. N. Nature 2009, 461, 968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Shen B.; Makley D. M.; Johnston J. N. Nature 2010, 465, 1027. [DOI] [PMC free article] [PubMed] [Google Scholar]; Shackleford J. P.; Shen B.; Johnston J. N. Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 44. [DOI] [PMC free article] [PubMed] [Google Scholar]; Leighty M. W.; Shen B.; Johnston J. N. J. Am. Chem. Soc. 2012, 134, 15233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Petrini M.; Torregiani E. Synthesis 2007, 2007, 159. [Google Scholar]
  8. Bunkóczi G.; Vértesy L.; Sheldrick G. M. Angew. Chem., Int. Ed. 2005, 44, 1340. [DOI] [PubMed] [Google Scholar]; Vertesy L.; Aretz W.; Knauf M.; Markus A.; Vogel M.; Wink J. J. Antibiot. 1999, 52, 374. [DOI] [PubMed] [Google Scholar]
  9. Barany M. J.; Hammer R. P.; Merrifield R. B.; Barany G. J. Am. Chem. Soc. 2004, 127, 508. [DOI] [PubMed] [Google Scholar]; Birkofer L.; Ritter A. Angew. Chem., Int. Ed. 1965, 4, 417. [Google Scholar]; Kricheldorf H. R. Justus Liebigs Ann. Chem. 1972, 763, 17. [DOI] [PubMed] [Google Scholar]; Mironov V. F.; Sheludyakov V. D.; Kozyukov V. P. Russ. Chem. Rev. 1979, 48, 473. [Google Scholar]
  10. Panunzio M.; Zarantonello P. Org. Process Res. Dev. 1998, 2, 49. [Google Scholar]
  11. Itsuno S.; Watanabe K.; El-Shehawy A. A. Adv. Synth. Catal. 2001, 343, 89. [Google Scholar]; Itsuno S.; Watanabe K.; Ito K.; ElShehawy A. A.; Sarhan A. A. Angew. Chem., Int. Ed. 1997, 36, 109. [Google Scholar]; Itsuno S.; Watanabe K.; Matsumoto T.; Kuroda S.; Yokoi A.; El-Shehawy A. J. Chem. Soc., Perkin Trans. 1 1999, 2011. [Google Scholar]; El-Shehawy A. A.; Abdelaal M. Y.; Watanabe K.; Ito K.; Itsuno S. Tetrahedron: Asymmetry 1997, 8, 1731. [Google Scholar]; Itsuno S.; Sasaki M.; Kuroda S.; Ito K. Tetrahedron: Asymmetry 1995, 6, 1507. [Google Scholar]
  12. However, Brown’s subsequent work revealed the importance of water in this reaction, suggesting that addition occurs after hydrolytic cleavage of the silyl protecting group. Therefore, enantioselective addition occurs to the free aldimine/borane complex, not to the putitive N-TMS imine:Chen G. M.; Ramachandran P. V.; Brown H. C. Angew. Chem., Int. Ed. 1999, 38, 825. [DOI] [PubMed] [Google Scholar]; Chen G. M.; Brown H. C. J. Am. Chem. Soc. 2000, 122, 4217. [Google Scholar]
  13. Bew S. P.; Fairhurst S. A.; Hughes D. L.; Legentil L.; Liddle J.; Pesce P.; Nigudkar S.; Wilson M. A. Org. Lett. 2009, 11, 4552. [DOI] [PubMed] [Google Scholar]
  14. Hong K.; Morken J. P. J. Am. Chem. Soc. 2013, 135, 9252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cainelli G.; Panunzio M.; Andreoli P.; Martelli G.; Spunta G.; Giacomini D.; Bandini E. Pure Appl. Chem. 1990, 62, 605. [Google Scholar]
  16. Vidal J.; Damestoy S.; Guy L.; Hannachi J. C.; Aubry A.; Collet A. Chem.—Eur. J. 1997, 3, 1691. [Google Scholar]
  17. Davis T. A.; Wilt J. C.; Johnston J. N. J. Am. Chem. Soc. 2010, 132, 2880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Davis T. A.; Johnston J. N. Chem. Sci. 2011, 2, 1076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Observation of this intermediate indicates that enantioselective addition does occur to the N-TMS imine and that the silyl group is not lost until acid chloride quench. See the Supporting Information for spectroscopic details.
  20. For similar observations with an indolenine electrophile, see:Dobish M. C.; Johnston J. N. Org. Lett. 2010, 12, 5744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nugent B. M.; Yoder R. A.; Johnston J. N. J. Am. Chem. Soc. 2004, 126, 3418. [DOI] [PubMed] [Google Scholar]
  22. Okino T.; Hoashi Y.; Takemoto Y. J. Am. Chem. Soc. 2003, 125, 12672. [DOI] [PubMed] [Google Scholar]; Song J.; Wang Y.; Deng L. J. Am. Chem. Soc. 2006, 128, 6048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. The absolute configuration was confirmed by quenching the intermediate pCl-TMS-adduct with Boc2O to form the N-Boc-protected α-bromo nitroamine, a known compound. See the Supporting Information for details.
  24. To the best of our knowledge, only one enantioselective synthesis of α-amino acids has shown some degree of tolerance to Fmoc protection directly (two substrates, hydrogenation to phenylalanine derivatives):Fernández-Pérez H.; Donald S. M. A.; Munslow I. J.; Benet-Buchholz J.; Maseras F.; Vidal-Ferran A. Chem.—Eur. J. 2010, 16, 6495. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ol501297a_si_001.pdf (501.2KB, pdf)
ol501297a_si_002.pdf (855.2KB, pdf)

Articles from Organic Letters are provided here courtesy of American Chemical Society

RESOURCES